These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 19468997)

  • 1. Common immunologic mechanisms in inflammatory bowel disease and spondylarthropathies.
    Fantini MC; Pallone F; Monteleone G
    World J Gastroenterol; 2009 May; 15(20):2472-8. PubMed ID: 19468997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory bowel diseases and spondyloarthropathies: From pathogenesis to treatment.
    Fragoulis GE; Liava C; Daoussis D; Akriviadis E; Garyfallos A; Dimitroulas T
    World J Gastroenterol; 2019 May; 25(18):2162-2176. PubMed ID: 31143068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut inflammation in the spondyloarthropathies.
    Mielants H; De Keyser F; Baeten D; Van den Bosch F
    Curr Rheumatol Rep; 2005 Jun; 7(3):188-94. PubMed ID: 15918994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunologic and genetic links between spondylarthropathies and inflammatory bowel diseases.
    Faustini F; Zoli A; Ferraccioli GF
    Eur Rev Med Pharmacol Sci; 2009 Mar; 13 Suppl 1():1-9. PubMed ID: 19530505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prevalence of extraintestinal manifestations and HLA association in patients with inflammatory bowel disease.
    Turkcapar N; Toruner M; Soykan I; Aydintug OT; Cetinkaya H; Duzgun N; Ozden A; Duman M
    Rheumatol Int; 2006 May; 26(7):663-8. PubMed ID: 16136311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Significance of intestinal inflammation in the pathogenesis of spondylarthropathies].
    Mielants H; Veys EM
    Verh K Acad Geneeskd Belg; 1996; 58(2):93-116. PubMed ID: 8768479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic intestinal inflammation and seronegative spondyloarthropathy in children.
    Conti F; Borrelli O; Anania C; Marocchi E; Romeo EF; Paganelli M; Valesini G; Cucchiara S
    Dig Liver Dis; 2005 Oct; 37(10):761-7. PubMed ID: 16024303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T-cell studies in the spondyloarthropathies.
    Märker-Hermann E; Schwab P
    Curr Rheumatol Rep; 2000 Aug; 2(4):297-305. PubMed ID: 11123074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune linkages between inflammatory bowel disease and spondyloarthropathies.
    Baeten D; De Keyser F; Mielants H; Veys EM
    Curr Opin Rheumatol; 2002 Jul; 14(4):342-7. PubMed ID: 12118165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastrointestinal lesions associated with spondyloarthropathies.
    Orlando A; Renna S; Perricone G; Cottone M
    World J Gastroenterol; 2009 May; 15(20):2443-8. PubMed ID: 19468992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current issues in pediatric inflammatory bowel disease-associated arthropathies.
    Cardile S; Romano C
    World J Gastroenterol; 2014 Jan; 20(1):45-52. PubMed ID: 24415857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory bowel disease-associated spondyloarthropathies.
    Fries W
    World J Gastroenterol; 2009 May; 15(20):2441-2. PubMed ID: 19468991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut inflammation and spondyloarthropathies.
    De Keyser F; Baeten D; Van den Bosch F; De Vos M; Cuvelier C; Mielants H; Veys E
    Curr Rheumatol Rep; 2002 Dec; 4(6):525-32. PubMed ID: 12427369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
    Pedersen G
    Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD40 and CD86 upregulation with divergent CMRF44 expression on blood dendritic cells in inflammatory bowel diseases.
    Vuckovic S; Florin TH; Khalil D; Zhang MF; Patel K; Hamilton I; Hart DN
    Am J Gastroenterol; 2001 Oct; 96(10):2946-56. PubMed ID: 11693331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The joint-gut axis in inflammatory bowel diseases.
    Brakenhoff LK; van der Heijde DM; Hommes DW; Huizinga TW; Fidder HH
    J Crohns Colitis; 2010 Sep; 4(3):257-68. PubMed ID: 21122514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging immunological targets in inflammatory bowel disease.
    Monteleone G; Pallone F; MacDonald TT
    Curr Opin Pharmacol; 2011 Dec; 11(6):640-5. PubMed ID: 22000933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Enteropathic spondylarthritis in chronic inflammatory bowel diseases: prevalence, manifestation pattern and HLA association].
    Protzer U; Duchmann R; Höhler T; Hitzler W; Ewe K; Wanitschke R; Meyer zum Büschenfelde KH; Märker-Hermann E
    Med Klin (Munich); 1996 Jun; 91(6):330-5. PubMed ID: 8767304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical features and epidemiology of spondyloarthritides associated with inflammatory bowel disease.
    Salvarani C; Fries W
    World J Gastroenterol; 2009 May; 15(20):2449-55. PubMed ID: 19468993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic bowel inflammation and inflammatory joint disease: Pathophysiology.
    Speca S; Dubuquoy L
    Joint Bone Spine; 2017 Jul; 84(4):417-420. PubMed ID: 28062378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.